● Recruiting

Phase III DAS181 Lower Tract PIV Infection in Immunocompromised Subjects (Substudy: DAS181 for COVID-19): RCT Study

Condition: Lower Respiratory Tract Infection · Parainfluenza · Immunocompromised · Sponsor: Ansun Biopharma, Inc.

PhasePhase 3

Planned participants274

Who can joinAll sexes, N/A to no upper limit

Healthy volunteersNo

About this study

This study will seek to enroll immunocompromised patients with Lower Tract parainfluenza infection. It also contains a sub-study to enroll patients with severe COVID-19.

This description comes directly from the study's public registry record.

Talk to the study team

Courtney Alcaraz · 619-988-2417 · cburke@ansunbiopharma.com

Always discuss trial participation with your own doctor first.

Locations (28)

City of Hope cancer Center	Duarte, California, United States	Recruiting
University of California Davis Health System	Sacramento, California, United States	Recruiting
Ann & Robert H. Lurie Children's Hospital of Chicago	Chicago, Illinois, United States	Recruiting
University of Iowa Health Care	Iowa City, Iowa, United States	Recruiting
University of Kansas Medical Center	Fairway, Kansas, United States	Recruiting
The Johns Hopkins Hospital	Baltimore, Maryland, United States	Withdrawn
Brigham and Women's Hospital	Boston, Massachusetts, United States	Recruiting
Mayo Clinic Rochester	Rochester, Minnesota, United States	Recruiting
Washington University	St Louis, Missouri, United States	Withdrawn
Weill Cornell Medical College	New York, New York, United States	Recruiting
Duke University	Durham, North Carolina, United States	Recruiting
Cincinnati Children's Hospital Medical Center	Cincinnati, Ohio, United States	Recruiting

+ 16 more locations — full list on the registry record.

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT03808922